BFA
ALXN
BlackRock Fund Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $674M | Buy |
5,510,165
+362,879
| +7% | +$44.4M | 0.12% | 141 |
|
|
2016
Q3 | $631M | Buy |
5,147,286
+582,338
| +13% | +$71.4M | 0.13% | 131 |
|
|
2016
Q2 | $533M | Buy |
4,564,948
+135,363
| +3% | +$15.8M | 0.12% | 153 |
|
|
2016
Q1 | $617M | Sell |
4,429,585
-66,503
| -1% | -$9.26M | 0.14% | 119 |
|
|
2015
Q4 | $858M | Sell |
4,496,088
-247,135
| -5% | -$47.1M | 0.2% | 80 |
|
|
2015
Q3 | $742M | Buy |
4,743,223
+10,707
| +0.2% | +$1.67M | 0.19% | 77 |
|
|
2015
Q2 | $855M | Buy |
4,732,516
+640,927
| +16% | +$116M | 0.21% | 68 |
|
|
2015
Q1 | $709M | Buy |
4,091,589
+507,351
| +14% | +$87.9M | 0.17% | 91 |
|
|
2014
Q4 | $663M | Buy |
3,584,238
+215,273
| +6% | +$39.8M | 0.16% | 97 |
|
|
2014
Q3 | $559M | Sell |
3,368,965
-756,502
| -18% | -$125M | 0.16% | 101 |
|
|
2014
Q2 | $645M | Sell |
4,125,467
-709,857
| -15% | -$111M | 0.18% | 76 |
|
|
2014
Q1 | $736M | Buy |
4,835,324
+982,674
| +26% | +$149M | 0.22% | 59 |
|
|
2013
Q4 | $512M | Buy |
3,852,650
+121,448
| +3% | +$16.1M | 0.16% | 93 |
|
|
2013
Q3 | $433M | Buy |
3,731,202
+204,069
| +6% | +$23.7M | 0.15% | 105 |
|
|
2013
Q2 | $325M | Buy |
+3,527,133
| New | +$325M | 0.12% | 140 |
|